At a glance
- Originator Scios
- Class Antibacterials
- Mechanism of Action Bradykinin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 04 Apr 1995 No-Development-Reported for Septic shock in USA (Unknown route)